MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-10-0059649
Seltas Pharma Private Limited
Seltas Pharma Private Limited - healthcare in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹21.87 Lakh
▲ 1712% YoY
Net profit · FY 2025
₹1.86 Lakh
Net margin 8.5%
EBITDA · FY 2025
₹2.72 Lakh
EBITDA margin 12.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Seltas Pharma Private Limited
Data last updated:
Seltas Pharma Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 12 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U85100WB2020PTC236411.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Archana Kumari and Tinkal Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B/1/H/5 Ripon Square, Kolkata, West Bengal, India – 700016.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.87 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.86 Lakh (net margin 8.5%) and EBITDA of ₹2.72 Lakh (EBITDA margin 12.4%).
Seltas Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0059649).
Company Details of Seltas Pharma Private Limited
CIN U85100WB2020PTC236411
Registration Number 236411
Incorporation Date 12 February 2020
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-WB-10-0059649
Key People
Archana Kumari Director Tinkal Kumari Director Recognitions & Rankings of Seltas Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressB/1/H/5 Ripon Square, Kolkata, West Bengal, India – 700016
- IndustryHealthcare, Human Health Activities
Comprehensive company report
Seltas Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Seltas Pharma Private Limited
The main business activity of Seltas Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Seltas Pharma Private Limited FY 2025 filings available
Seltas Pharma Private Limited reported revenue of ₹21.87 Lakh (up 1712% YoY) for FY 2025.
Revenue · FY 2025
₹21.87 Lakh ▲ 1712%
Net profit · FY 2025
₹1.86 Lakh margin 8.5%
EBITDA · FY 2025
₹2.72 Lakh margin 12.4%
Financial Statement Summary of Seltas Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.72 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.86 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Seltas Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 8.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Seltas Pharma are in the company report.
Premium access
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Seltas Pharma Private Limited
Seltas Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Archana Kumari | Director | 03 Jan 2021 | 5 Years 9 Months | Current |
| Tinkal Kumari | Director | 17 Apr 2023 | 3 Years 6 Months | Current |
Peer Comparison of Seltas Pharma Private Limited
Seltas Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Casomed Pharmaceuticals Private Limited | ₹21.99 Lakh (FY 2022) | •••• | •••• | -16.0% | •••• | Chennai, Tamil Nadu, India |
| Advait Pharmasol Private Limited | ₹21.98 Lakh (FY 2024) | •••• | •••• | 8433.0% | •••• | Mumbai, Maharashtra, India |
| Bansal Medical Centre Pvt Ltd | ₹21.97 Lakh (FY 2021) | •••• | •••• | -54.0% | •••• | Hisar, Haryana, India |
| Warku Pharmaceuticals Private Limited | ₹21.94 Lakh (FY 2025) | •••• | •••• | 637.0% | •••• | Bareilly, Uttar Pradesh, India |
| Haskins Healthcare Private Limited | ₹21.87 Lakh (FY 2025) | •••• | •••• | -19.0% | •••• | Chennai, Tamil Nadu, India |
| Seltas Pharma Private Limited this company | ₹21.87 Lakh (FY 2025) | •••• | •••• | 1712.0% | •••• | Kolkata, West Bengal, India |
| Potion Pharmaceuticals Private Limited | ₹21.85 Lakh (FY 2025) | •••• | •••• | 9509.0% | •••• | Mumbai, Maharashtra, India |
| Ocular Medisyne Private Limited | ₹21.77 Lakh (FY 2024) | •••• | •••• | •••• | Patna, Bihar, India | |
| Neoindus Pharma Private Limited | ₹21.7 Lakh (FY 2025) | •••• | •••• | -47.0% | •••• | Bangalore, Karnataka, India |
| Natureshine Herbals Private Limited | ₹21.66 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | Chennai, Tamil Nadu, India |
| Soprano Trading Private Limited | ₹21.63 Lakh (FY 2020) | •••• | •••• | 908.0% | •••• | Hisar, Haryana, India |
Peers are the five companies nearest above and the five nearest below Seltas Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Seltas Pharma Private Limited
Seltas Pharma Private Limited is audited by M/s Harmeet Singh for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M/s Harmeet Singh | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Seltas Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Seltas Pharma Private Limited
Seltas Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Seltas Pharma Private Limited
Employment history and EPFO contributions of people linked to Seltas Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Seltas Pharma Private Limited
Seltas Pharma Private Limited has 6 board changes on record since 2021: 2 appointments and 4 cessations. The latest: Sadhana Singh ceased to be Director on 18 Apr 2023.
AGM
Seltas Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Seltas Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I.
Ceased
Sadhana Singh ceased to be Director.
Ceased
Sonam Kumari ceased to be Director.
Ceased
Vivek Kumar ceased to be Director.
Appointed
Tinkal Kumari was appointed as Director.
Ceased
Anupa Kumari ceased to be Director.
Appointed
Archana Kumari was appointed as Director.
Incorporation
12 Feb 2020
Seltas Pharma Private Limited was registered on 12 Feb 2020 with Roc Kolkata I & aged 6 years 8 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Seltas Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Seltas Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Seltas Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Seltas Pharma Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Seltas Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Seltas Pharma Private Limited
Seltas Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in human health activities, within the healthcare industry. It was incorporated on 12 February 2020 (6+ years old) and is registered under CIN U85100WB2020PTC236411.
Seltas Pharma reported revenue of ₹21.87 Lakh for FY 2025 (up 1712% YoY).
Seltas Pharma has 2 current directors:
- Archana Kumari - Director
- Tinkal Kumari - Director
Seltas Pharma reported a net profit of ₹1.86 Lakh (net margin 8.5%) and EBITDA of ₹2.72 Lakh (EBITDA margin 12.4%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Seltas Pharma is U85100WB2020PTC236411. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Seltas Pharma was incorporated on 12 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Seltas Pharma by revenue are Casomed Pharmaceuticals Private Limited, Advait Pharmasol Private Limited, Bansal Medical Centre Pvt Ltd, Warku Pharmaceuticals Private Limited, Haskins Healthcare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Sadhana Singh ceased to be Director on 18 Apr 2023. Sonam Kumari ceased to be Director on 18 Apr 2023. Vivek Kumar ceased to be Director on 18 Apr 2023. Seltas Pharma has 6 board changes on record in total.
Yes, Seltas Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-10-0059649).
The registered office of Seltas Pharma is at B1H5 Ripon Square, Kolkata, West Bengal, India – 700016.
Seltas Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.